The moral tollbooth: a method that makes use of the patent system to address ethical concerns in biotechnology
- 1 June 2002
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 359 (9325), 2268-2270
- https://doi.org/10.1016/s0140-6736(02)09298-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The European Biotech Directive: Past as PrologueEuropean Law Journal, 2001
- British Parliament Approves New RulesScience, 2001
- Avoiding FrankendrugsNature Biotechnology, 2000
- Moving the gene patent debate forwardNature Biotechnology, 2000
- Patenting human genetic material: refocusing the debateNature Reviews Genetics, 2000
- Families Sue Hospital, Scientist for Control of Canavan GeneScience, 2000
- Rational limits on genomic patentsNature Biotechnology, 2000
- Reforming the Patent SystemScience, 2000
- Commercialization of Genetic Research and Public PolicyScience, 1999
- Can Patents Deter Innovation? The Anticommons in Biomedical ResearchScience, 1998